Skip to main content

Table 1 Clinical and tumor characteristics

From: A prospective single-arm study on the relationship between dose-volume parameters of pelvic functional bone marrow and acute hematological toxicities during intensity-modulated radiotherapy with or without concurrent chemotherapy for uterine cervical/endometrial cancer

Characteristic

Number(%)

Age, year

Median, 52 (Range,33 ~ 79)

Height, cm

Median, 56.6 (Range,140 ~ 168)

Weight, kg

Median, 56 (Range,36 ~ 90)

BMI, kg/m²

Median, 22.43 (Range, 15.6 ~ 34.7)

Types of gynecologic tumors

 

 Uterine cervical cancer

72(74.2)

 Endometrial cancer

25(25.8)

Pathological type of uterine cervical cancer

 

 Squamous cell carcinoma

58(59.8)

 Adenocarcinoma

10(10.3)

 Neuroendocrine carcinoma

3(3.1)

 Adenosquamous carcinoma

1(1.0)

Stage of uterine cervical cancer

 

 IA2

1(1.0)

 IB1

12(12.4)

 IB2

8(8.2)

 IB3

1(1.0)

 IIA1

2(2.1)

 IIA2

9(9.3)

 IIB

18(18.6)

 IIIA

1(1.0)

 IIIA

1(1.0)

 IIIC1

19(19.6)

 IVA

1(1.0)

Pathological type of endometrial cancer

 

Endometrioid adenocarcinoma

20(20.6)

Squamous cell carcinoma

1(1.0)

Clear cell carcinoma

3(3.1)

Papillary serous carcinoma

1(1.0)

Stage of endometrial cancer

 IA

2(2.1)

 IB

4(4.1)

 II

9(9.3)

 IIIA

4(4.1)

 IIIC1

5(5.2)

 IVA

1(1.0)

Pathological grade

 

 G1

3(3.1)

 G2

32(33)

 G3

38(39.2)

 Gx

24(24.7)

Leukopenia before radiotherapy

 

 0°

83(85.6)

 1°

14(14.4)

Neutropenia before radiotherapy

 

 0°

92(94.8)

 1°

5(5.2)

Anemia before radiotherapy

 

 0°

64(66)

 1°

16(16.5)

 2°

17(17.5)

Thrombocytopenia before radiotherapy

 

 0°

96(99)

 1°

1(1)